Abstract
Thyroid storm during pregnancy is rare but put the mothers and the neonates in a critical condition that can culminate to high morbidity and mortality and need to be diagnosed and managed appropriately. Clinical findings of thyroid storm are exaggerated form of the usual symptoms of hyperthyroidism. The diagnosis of thyroid storm is based upon clinical and laboratory findings. The first-line therapy in treating thyroid storm consists of using thionamides (Methimazole, Propylthiouracil), which halt new thyroid hormone production; PTU has an additional benefit of reducing the peripheral conversion of T4 to T3 which is a more favorable treatment option. New thyroid hormone synthesis can be blocked by adding nonradioactive iodine in the form of SSKI or Lugol’s solution. General supportive measures, such as antipyretic drugs, and cardiovascular monitoring, maintaining normal oxygen level, are also important. The perceived underlying cause of thyroid storm should be treated.
Natural course of neonatal hyperthyroidism shows that it usually is self-limited, but it can be severe, even life-threatening, and may have deleterious effects on neural development. Neonatal hyperthyroidism can occur in babies whose mothers have active Graves’ disease or who are born to women with a stimulatory TSHR-Ab associated with Hashimoto thyroiditis due to trans-placental passage of the maternal stimulatory TSH receptor antibody; it also can occur in infants of women who do not have active disease during pregnancy but has a history of Graves’ hyperthyroidism treated either with radioactive iodine or thyroidectomy previously and the level of stimulatory TSHR-Ab remained high during pregnancy. Elevated FT4, TT4, and total T3, with low TSH, are infamous of neonatal Graves’ disease. Thionamides are the drug of choice for controlling the disease. A beta-adrenergic blocker can be added to control symptoms of neuromuscular and cardiovascular hyperactivity. Iodine can be given to inhibit thyroid hormone release in severe form of the disease. A multidisciplinary team approach is critical for management of thyroid storm during pregnancy in order to successfully give the patients who suffer from thyroid storm all possible diagnostic and therapeutic options.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andersen SL, Olsen J, Carle A, Laurberg P. Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a Danish population-based study. J Clin Endocrinol Metab. 2015;100(3):1164–71.
Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702–55.
Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994;84(6):946–9.
Wang HI, Yiang GT, Hsu CW, Wang JC, Lee CH, Chen YL. Thyroid storm in a patient with trauma—a challenging diagnosis for the emergency physician: case report and literature review. J Emerg Med. 2017;52(3):292–8.
Waltman PA, Brewer JM, Lobert S. Thyroid storm during pregnancy. A medical emergency. Crit Care Nurse. 2004;24(2):74–9.
Chiha M, Samarasinghe S, Kabaker AS. Thyroid storm: an updated review. J Intensive Care Med. 2015;30(3):131–40.
Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol. 2004;190(1):211–7.
Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22(2):263–77.
Besancon A, Beltrand J, Le Gac I, Luton D, Polak M. Management of neonates born to women with Graves’ disease: a cohort study. Eur J Endocrinol. 2014;170(6):855–62.
Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K, Tanizawa O. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol. 1992;80(3 Pt 1):359–64.
Kiefer FW, Klebermass-Schrehof K, Steiner M, Worda C, Kasprian G, Diana T, et al. Fetal/neonatal thyrotoxicosis in a newborn from a hypothyroid woman with Hashimoto thyroiditis. J Clin Endocrinol Metab. 2017;102(1):6–9.
Volpe R, Ehrlich R, Steiner G, Row VV. Graves’ disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves’ disease in offspring. Therapeutic considerations. Am J Med. 1984;77(3):572–8.
van Dijk MM, Smits IH, Fliers E, Bisschop PH. Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis: a systematic review. Thyroid. 2018;28(2):257–64.
McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid. 1992;2(2):155–9.
Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315–89.
Polak M, Legac I, Vuillard E, Guibourdenche J, Castanet M, Luton D. Congenital hyperthyroidism: the fetus as a patient. Horm Res. 2006;65(5):235–42.
van der Kaay DC, Wasserman JD, Palmert MR. Management of neonates born to mothers with Graves’ disease. Pediatrics. 2016;137(4):e20151878.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Amouzegar, A. (2022). Thyroid Storm and Neonatal Hyperthyroidism. In: Azizi, F., Ramezani Tehrani, F. (eds) Thyroid Diseases in Pregnancy. Springer, Cham. https://doi.org/10.1007/978-3-030-98777-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-98777-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-98776-3
Online ISBN: 978-3-030-98777-0
eBook Packages: MedicineMedicine (R0)